文献速递病毒性肝炎

美国国家实验室丙肝反射性检测趋势:2018至2024年回顾性研究

Trends in Reflexive Hepatitis C Virus Testing in a National US Laboratory: A Retrospective Study From 2018 to 2024.
PubMed 文献 · Clin Infect Dis · 2026-01-01

结果显示,丙肝抗体阳性者中反射性检测比例由2018年21.9%升至2024年82.2%,RNA检测率由66.4%升至89.3%,当日RNA检测率由38.0%升至82.2%,HCV RNA阳性率下降19.2%。

要点

  • 扩大筛查指南与实验室管理举措可能提升反射性HCV检测利用率
  • 抗体阳性者反射性检测比例由21.9%升至82.2%
  • 抗体阳性者RNA检测率由66.4%升至89.3%,当日检测率由38.0%升至82.2%

核心结论

  • 扩大丙肝筛查指南强调反射性HCV检测的重要性,加之实验室内部管理举措,可能促进反射性检测利用率提高并缩短活动性感染识别时间。
  • 研究期间HCV RNA阳性率下降19.2%。

研究设计与样本

  • 评估扩大丙肝指南与实验室管理举措的影响。

主要发现

  • 2018至2024年反射性丙肝检测量逐年增加,单独HCV抗体检测订单与抗体阳性率稳步下降。
  • 抗体阳性者中反射性检测比例由2018年21.9%升至2024年82.2%(Ƭ=1.00,P=.003)。
  • 抗体阳性者RNA检测率由2018年66.4%升至2024年89.3%(Ƭ=1.00,P=.003)。
  • 抗体阳性者当日RNA检测率由2018年38.0%升至2024年82.2%。
  • 研究期间HCV RNA阳性率下降19.2%。

关键数值与推荐

  • 2019与2020年临床指南机构(包括CDC)推荐成人普遍丙肝筛查。
  • 2023年CDC建议强调反射性丙肝检测,即HCV抗体阳性样本自动反射至病毒RNA核酸检测。
  • 反射性检测比例82.2%(2024年,抗体阳性者)。
  • RNA检测率89.3%(2024年,抗体阳性者)。
  • 当日RNA检测率82.2%(2024年,抗体阳性者)。

临床怎么用

  • 对HCV抗体阳性样本实施自动反射RNA核酸检测,可提高检测完成率并缩短活动性感染识别时间。
  • 实验室层面建立反射性检测流程与管理举措,有助于落实扩大筛查指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2019 and 2020, universal hepatitis C screening of adults was recommended by clinical guideline authorities, including the Centers for Disease Control and Prevention (CDC). In 2023, CDC recommendations emphasized the importance of reflexive hepatitis C testing in which samples positive for hepatitis C virus (HCV) antibody (Ab) automatically reflex to viral RNA nucleic acid amplification testing (NAAT). Laboratory stewardship initiatives to guide compliance with expanded guidelines were implemented. METHODS: We conducted a retrospective review of 38 233 788 specimens with HCV Ab testing and 1 423 543 follow-up HCV RNA NAAT performed from 2018 to 2024 to evaluate the impact of expanded hepatitis C guidelines and laboratory stewardship initiatives. RESULTS: From 2018 to 2024, reflexive hepatitis C testing volumes increased annually, while orders for standalone HCV Ab testing and HCV Ab positivity rates steadily declined. Among HCV Ab-positive individuals, the percentage with reflexive testing increased from 21.9% in 2018 to 82.2% in 2024 (Ƭ = 1.00, P = .003) and RNA testing rates increased from 66.4% in 2018 to 89.3% in 2024 (Ƭ = 1.00, P = .003). Follow-up RNA testing was increasingly completed earlier in HCV Ab-positive individuals with the same-day RNA testing rate increasing from 38.0% in 2018 to 82.2% in 2024. HCV RNA positivity decreased 19.2% during the study period. CONCLUSIONS: Expanded hepatitis C screening guidelines highlighting the importance of reflexive HCV testing and subsequent internal laboratory stewardship initiatives likely contributed to the increased utilization of reflexive hepatitis C testing and the decreased time to identification of active hepatitis C infection.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Lee MK, Alfego D, Walworth C, et al. Trends in Reflexive Hepatitis C Virus Testing in a National US Laboratory: A Retrospective Study From 2018 to 2024. Clin Infect Dis. 2026. PMID: 41964422. doi:10.1093/cid/ciag227

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。